We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: In a new study, researchers discovered that testing blood-based liquid biopsy samples for genomic mutations in ctDNA could help reveal which patients would likely respond to CIIs (Photo courtesy of John Shepherd).

Blood Test Predicts Patient Response to Immunotherapy

In a first-of-its-kind study in the field, researchers found that testing blood-based liquid biopsy samples for genomic mutations in circulating tumor DNA (ctDNA) could help reveal which patients would likely respond to checkpoint inhibitor-based immunotherapies (CIIs). More...
09 Oct 2017
Image: A new paper-based immunoassay rapidly distinguishes between Zika and dengue virus infections (Photo courtesy of the Massachusetts Institute of Technology).

Paper-based Immunoassay Distinguishes Zika and Dengue Infections

A rapid, easy-to-use immunoassay identifies individuals with Zika virus infection with no false positive results due to dengue virus or other flaviviruses. More...
09 Oct 2017
Image: The Oragene saliva kits for collecting reliable samples with an all-in-one system for the collection, stabilization and transportation of DNA from saliva (Photo courtesy of DNAGenotek).

Another Key Gene Discovered for Alzheimer’s Disease

The consensus among scientists has been that the Apolipoprotein E (ApoE4) gene is the main marker of Alzheimer's disease and many other dementias, but a new study has added another key player into the mix. More...
05 Oct 2017
Image: Immunohistochemistry of estrogen-receptor-positive (ER (+)) breast cancer (Photo courtesy of Biocare Medical).

Genetic Test Discovered for Predicting Cancer Recurrence

Treatment failure, due to drug resistance, still remains a major obstacle for more effective anti-cancer therapy and personalized medicine. In estrogen-receptor-positive (ER (+)) breast cancer, approximately 40% to 50% of patients eventually develop tamoxifen-resistance. More...
04 Oct 2017
Image: The Accuri C6 Plus flow cytometer (Photo courtesy of BD Biosciences).

New Markers Revealed for Severe Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic condition that affects an estimated 2.3 million people worldwide. In MS, the sheath covering nerve fibers in the brain and spinal cord becomes damaged, slowing or blocking electrical signals from the brain reaching the eyes, muscles, and other parts of the body. More...
03 Oct 2017
Image: The Implen Nanophotometer all-in-one spectrometer (Photo courtesy of Implen).

Rapid Alternative to Standard Safety Tests Introduced

Lentiviruses are a type of retrovirus commonly used by scientists to introduce new genes into therapeutic chimeric antigen receptor T cells (CAR-T cells), which are introduced back into patients to fight cancer. More...
03 Oct 2017
Image: A ribbon model of an X-ray diffraction based 3D structure of FANCM- FAAP24 complex, as shown in ID# 4BXO of the Protein Database (PDB) (Photo courtesy of Coulthard R et al, 2013, PDB).

Discovered Inherited Syndrome Predisposes Body to Cancer

The syndrome was found and characterized by studying patients with biallelic mutations (mutations in both inherited gene copies) in the FANCM gene. These mutations predisposed the body to development of tumors and to hypersensitivity to and rejection of chemotherapy treatments. Contrary to what has been thought, the study suggests that mutations in the FANCM gene does not cause Fanconi anemia, a rare disease that affects ~ 1 of every 100,000 children. More...
02 Oct 2017
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automatic CLIA Analyzer
Shine i9000


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.